Pharsight Monthly Summary
July, 2026
Recent happenings in patent protected drugs.
spacer_11
At a Glance
157
drug patents lapsed
Photos
101
new drug patents introduced
Reviews
What's New on Pharsight?

Patent Challenge Updates

Discover for which innovator drugs Paragraph IV certifications have been filed, signaling opportunities to launch generics before patent expiry. Find this section right under Generic Launch on any drug page to stay ahead of the market and identify actionable opportunities.

Recent & Tentative Approvals

Track the latest innovator and generic drug approvals along with tentative approvals and submission timelines to identify drugs moving closer to market entry. This helps uncover pipeline momentum, anticipate upcoming launches, and better understand how a company’s portfolio is evolving. Simply search for any company on Pharsight and find this in the Recent Approvals & Tentative Approvals section of the company page.

spacer_11
spacer_11
spacer_11

High Competition Drugs Alert
See which drugs have the most crowded generic market and intense competition right now.
Drug (ANDA Filed) Primary Patent Status Market Size
Eliquis 25 Expiring Soon $13.3B
Latuda 14 Expired -
Bridion 14 Expired $1.8B
Tradjenta 11 Expired -
Opsumit 11 Expired $2.3B
Kyprolis 9 Expired -
Jentadueto 8 Expired -

Drug patents lapsed
Spot drugs with expired patents that present new generic development opportunities.
Drug Patent Patent expiry
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
Abilify 9125939 28 Jul, 2026
See more

Newly introduced Drug Patents
Discover the latest drugs receiving patent protection, signaling innovation and new market entrants
Drug Patent Patent expiry
Aristada 12629366 06 Dec, 2032
Auvelity 10064857 05 Nov, 2034
Auvelity 10092561 05 Nov, 2034
Auvelity 10463634 05 Nov, 2034
Auvelity 10512643 05 Nov, 2034
Auvelity 10881624 05 Nov, 2034
Auvelity 9278095 05 Nov, 2034
See more

Recent patent litigations
Stay updated on recent drug patent lawsuits shaping the competitive landscape.
Patent Petitioner Proceeding Date
US12280146 Sun Pharmaceutical Industries, Inc. 16 Jan, 2026
US12233106 Ascendis Pharma A/s 24 Nov, 2025
US11344552 Apotex Inc. 12 Sep, 2025
US9474780 Bpi Labs, Llc 04 Aug, 2025
US8268847 United Therapeutics Corporation 10 Jun, 2025
US9474780 Empower Clinic Services, Llc. (D/b/a Empower Pharmacy) 22 May, 2025
US8623826 Azurity Pharmaceuticals, Inc. 01 May, 2025
See in detail
spacer_11
Companies with Newly Granted Drug Substance Patents
Company Ingredient
Actelion Selexipag
Astrazeneca Ab Eplontersen Sodium
Novo Semaglutide
Orphalan Trientine Tetrahydrochloride
Shionogi Ensitrelvir
Wockhardt Bio Ag Cefepime Hydrochloride; Zidebactam
spacer_11
View past newsletters
January, 2026
December, 2025
November, 2025

Our insights are consumed by 1000+ leading pharma companies

© 2026 GreyB Research